The amount of the deal was not disclosed.
With this acquisition, Brainlab creates an openly scalable medical robotics platform paired with an efficient software ecosystem.
This strategic move increases the depth of the Brainlab portfolio in cranial surgery and strengthens its offering in spinal surgery, contributing a digital step in clinical workflows.
The company currently markets the Medineering arm under the name Cirq®. Inspired by the form of the human arm, Cirq is an intuitive assistant during surgical procedures. After quick setup, Cirq can be aligned in seven degrees of freedom for maximum positioning flexibility. Once Cirq is locked firmly in place, surgeons are free to focus on subsequent surgical steps with both hands. Navigation integration leverages established workflows, set-up and instrumentation, and extends utilization.
Stefan Vilsmeier, President and CEO, Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. The technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in 1989, Brainlab has more than 12,850 systems installed in over 100 countries. The company employs almost 1,400 people in 18 offices worldwide, including more than 420 research and development engineers.
Founded in June 2014 by Dr. Maximilian Krinninger and Dr. Stephan Nowatschin, Medineering develops, manufactures and markets an application-specific and convenient robotic portfolio. The portfolio consists of the Medineering Positioning Arm and compact application-specific robots assisting surgeons in complex anatomical regions.